Cargando…
HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru
INTRODUCTION: Transmitted, or any pretreatment drug resistance (TDR, PDR) can compromise efficacy of first‐line antiretroviral therapy (ART). In Peru, genotypic resistance testing is not routinely performed before ART initiation, and estimated PDR prevalence prior to 2012 ranged from 1.0% to 4.7%. W...
Autores principales: | Trebelcock, William L, Lama, Javier R, Duerr, Ann, Sanchez, Hugo, Cabello, Robinson, Gilada, Trupti, Segura, Patricia, Reisner, Sari L, Mayer, Kenneth H, Mullins, James, Bender Ignacio, Rachel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880186/ https://www.ncbi.nlm.nih.gov/pubmed/31773888 http://dx.doi.org/10.1002/jia2.25411 |
Ejemplares similares
-
HIV transmission patterns among transgender women, their cisgender male partners, and cisgender MSM in Lima, Peru: A molecular epidemiologic and phylodynamic analysis
por: Long, Jessica E., et al.
Publicado: (2021) -
“Existimos”: Health and social needs of transgender men in Lima, Peru
por: Reisner, Sari L., et al.
Publicado: (2021) -
The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru
por: Perez‐Brumer, Amaya, et al.
Publicado: (2021) -
Leveraging social capital: multilevel stigma, associated HIV vulnerabilities, and social resilience strategies among transgender women in Lima, Peru
por: Perez-Brumer, Amaya G., et al.
Publicado: (2017) -
1517. Sexual Network Characteristics of MSM with Detectable Viremia Living with HIV in Lima, Peru
por: Harris, Carlyn L, et al.
Publicado: (2023)